New Chernobyl Initiative Aims to Boost Research on the Area

Sergii Mirnyi, one of the people who helped clean up after the 1986 disaster, says he founded Chornobyl University to promote much-needed interdisciplinary research on the Chernobyl Exclusion Zone.

Written byStefan Weichert
| 5 min read
Ionizing Radiation sign near Chernobyl nuclear power plant zone of alienation, Ukraine

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

ABOVE: © ISTOCK.COM, KOTANGENS

Sixty-two-year-old Sergii Mirnyi will never forget the year 1986, when he was sent to help deal with the nuclear disaster in Chernobyl that was threatening to poison the continent. Mirnyi was a reserve lieutenant in the Soviet Army, a physical chemist, and a chemical task force leader who led a team of so-called liquidators tasked with measuring radiation and evacuating villages near Chernobyl in the months following the accident.

Mirnyi went back to working as a physical chemist after the disaster, but what he had witnessed—particularly the evacuations and the upheaval for people affected by the event—stuck with him and became the center of his research years later when he started studying the long-term health of liquidators. In 2008, he founded the company Chernobyl Tours, which takes tourists into the 2,600-square-kilometer Chernobyl Exclusion Zone to educate them about radiation. Last year, Mirnyi went a step further, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Stefan Weichert

    Stefan is a freelance writer based in Ukraine who focuses on the post-Soviet countries. He has a journalism master’s degree focusing on war, conflict, and terrorism from Swansea University in Wales. His work focuses on social issues and has been featured in media outlets such as Euronews, DW, The Daily Beast, and others.

    View Full Profile

Published In

Online only cover of the The Scientist, September 2021 issue
September 2021

Mapping Covid

SARS-COV-2 wreaks havoc around the body

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies